BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11785773)

  • 1. tGLP-1 and release of vasopressin and oxytocin from the isolated rat hypothalamo-neurohypophysial system: effects of a tGLP-1 receptor agonist and antagonist.
    Bojanowska E; Stempniak B
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):781-93. PubMed ID: 11785773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms involved in glucagon-like peptide-1 (7-36) amide action on the rat hypothalamo-neurohypophysial system.
    Bojanowska E; Stempniak B
    Neuroendocrinology; 2003 Feb; 77(2):119-24. PubMed ID: 12624533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. tGLP-1 action on the isolated hypothalamo-neurohypophysial system under glutamate receptor blockade.
    Bojanowska E; Stempniak B
    Brain Res Bull; 2002 Sep; 58(6):555-9. PubMed ID: 12372558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucagon-like peptide-1(7-36) amide on neurohypophysial and cardiovascular functions under hypo- or normotensive hypovolaemia in the rat.
    Bojanowska E; Stempniak B
    J Endocrinol; 2002 Feb; 172(2):303-10. PubMed ID: 11834448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
    Larsen PJ; Tang-Christensen M; Jessop DS
    Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurokinin A and the neurohypophysial response to melatonin: in vitro studies.
    Juszczak M
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 2):823-34. PubMed ID: 12510866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forskolin-stimulated vasopressin and oxytocin release from the rat hypothalamo-neurohypophysial system in vitro is inhibited by melatonin.
    Roszczyk M; Juszczak M
    Endokrynol Pol; 2014; 65(2):125-31. PubMed ID: 24802736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galanin and galanin-like peptide modulate vasopressin and oxytocin release in vitro: the role of galanin receptors.
    Wodowska J; Ciosek J
    Neuropeptides; 2014 Dec; 48(6):387-97. PubMed ID: 25464889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland.
    Larsen PJ; Jukes KE; Chowdrey HS; Lightman SL; Jessop DS
    Endocrinology; 1994 Apr; 134(4):1635-9. PubMed ID: 8137725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohypophysial response to peptides of the cholecystokinin family: in vivo and in vitro studies.
    Morawska-Barszczewska J; Lewandowska A; Guzek JW
    Pol J Pathol; 1994; 45(2):163-71. PubMed ID: 8062068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats.
    Ciosek J; Cisowska A
    J Physiol Pharmacol; 2003 Dec; 54(4):625-41. PubMed ID: 14726616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone (TRH) modulates vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in dehydrated rats.
    Ciosek J; Guzek JW; Orłowska-Majdak M
    J Physiol Pharmacol; 1993 Sep; 44(3):293-302. PubMed ID: 8241530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line.
    Crespel A; De Boisvilliers F; Gros L; Kervran A
    Endocrinology; 1996 Sep; 137(9):3674-80. PubMed ID: 8756532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic gonadotropin-releasing hormone receptor activation stimulates oxytocin release from the rat hypothalamo-neurohypophysial system while melatonin inhibits this process.
    Juszczak M; Boczek-Leszczyk E
    Brain Res Bull; 2010 Jan; 81(1):185-90. PubMed ID: 19874874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of thyroliberin on vasopressin and oxytocin release from the hypothalamo-neurohypophysial system under in vivo and in vitro conditions].
    Ciosek J
    Postepy Hig Med Dosw (Online); 2007 Jul; 61():429-37. PubMed ID: 17679913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tGLP-1 on feeding behaviour and neurohypophysial function under chronic osmotic stimulation.
    Bojanowska E; Stempniak B
    Physiol Behav; 2003 Jan; 78(1):73-9. PubMed ID: 12536013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin affects vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in haemorrahaged rats.
    Ciosek J; Cisowska A; Dabrowski R
    J Physiol Pharmacol; 2003 Jun; 54(2):233-46. PubMed ID: 12832724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glucagon-like peptide-1 (7-36) amide on neurohypophysial hormone secretion induced by acute hyperosmotic challenge.
    Bojanowska E; Stempniak B
    Neuropeptides; 2003 Feb; 37(1):45-50. PubMed ID: 12637035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin inhibits the substance P-induced secretion of vasopressin and oxytocin from the rat hypothalamo-neurohypophysial system: in vitro studies.
    Juszczak M; Stempniak B
    Brain Res Bull; 2003 Jan; 59(5):393-7. PubMed ID: 12507691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone modulates vasopressin and oxytocin synthesis and release from the hypothalamo-neurohypophysial system of different age male rats.
    Ciosek J; Izdebska K
    J Physiol Pharmacol; 2009 Jun; 60(2):63-70. PubMed ID: 19617647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.